ClinicalTrials.gov
public full text
Public Domain
A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma
This is a phase II, open-label, single center study, aiming to investigate safety and efficacy of anlotinib in treatment of recurrent high-grade glioma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma#879144
- Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer#838319
- A Study of Abemaciclib in Recurrent Glioblastoma#854304
- Adjuvant Therapy With Anlotinib for HCC#919107
- Chemotherapy in Treating Patients With Recurrent Malignant Glioma#1115222
Record · ID 850949
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive